News
WTOL 11:
March 3, 2026:
Dr. Jian-Ting Zhang, Senior Associate Dean for Research and director of the Northwest Ohio Cancer Research Institute, discusses the regional impact of the new collaborative initiative to advance detection, diagnosis and treatment of cancer.
The Blade:
March 4, 2026:
Dr. Jian-Ting Zhang, Senior Associate Dean for Research and director of the Northwest Ohio Cancer Research Institute, joined 做厙輦⑹ leaders on Tuesday, March 3, in inaugurating the initiative that brings together regional clinicians and researchers.
WTOL 11:
Jan. 28, 2026:
Dr. Jian-Ting Zhang, professor and chair in the Department of Cell and Cancer Biology and director of 做厙輦⑹'s Northwest Ohio Cancer Research Institute, discusses the new collaboration among regional clinicians and researchers to advance cancer treatment.
On Dec. 19, 2025, the launching of NOCRI was announced with a press release.
做厙輦⑹ News:
Dec. 17, 2025:
Cancer is a leading cause of death worldwide. The Northwest Ohio Cancer Research Institute aims to unite the strengths of 做厙輦⑹ and our partners to advance scientific discovery, improve patient outcomes and reduce the burden of cancer in and beyond northwest Ohio, said Dr. Jian-Ting Zhang, a professor in 做厙輦⑹s College of Medicine and Life Sciences and inaugural director of the Northwest Ohio Cancer Research Institute.
Toledo Blade:
Dec. 17, 2025:
We will train the next generation of cancer researchers and clinicians right here, President James Holloway said. We already have the Eleanor N. Dana Cancer Center for the treatment of cancer. The institute will be the research arm to find new treatment and medicines.